QUEST DIAGNOSTICS INC
DGXUnited States
83 filed reports · 510 financial concepts · 2 earnings calls · 5 media appearances
Filed reports
83 reports · Mar 2016 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 70 operating metrics, 392 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Current · 8-KSEC EDGAR | 41 | 351 | Jun 2016 to Jun 2026 |
| Quarterly · 10-QSEC EDGAR | 32 | 5,442 | Mar 2016 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 10 | 6,203 | Dec 2016 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Jul 23, 2026 | 358 | Open |
| FY2026 Q2 | 8-K | Jun 30, 2026 | Jul 23, 2026 | 5 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | Apr 22, 2026 | 230 | Open |
| FY2026 Q1 | 8-K | Mar 31, 2026 | Apr 21, 2026 | 8 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 26, 2026 | 1,165 | Open |
| FY2025 Q4 | 8-K | Dec 31, 2025 | Feb 10, 2026 | 9 | Open |
| FY2025 Q4 | 8-K | Dec 31, 2025 | Jan 12, 2026 | 2 | Open |
| FY2025 Q3 | 8-K | Sep 30, 2025 | Oct 21, 2025 | 4 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Oct 21, 2025 | 255 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Jul 23, 2025 | 157 | Open |
| FY2025 Q2 | 8-K | Jun 30, 2025 | Jul 22, 2025 | 8 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | Apr 23, 2025 | 148 | Open |
Financial data
510 concepts · 11,996 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial486 concepts · 10,673 facts · Dec 2014 to Jul 2026
- Cash and cash equivalents at carrying value59 · Dec 2014 to Jun 2026
- Dividends payable current and noncurrent59 · Dec 2014 to Jun 2026
- Stockholders equity including portion attributable to noncontrolling interest59 · Dec 2014 to Jun 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value58 · Dec 2014 to Jun 2026
- Amortization of intangible assets58 · Dec 2014 to Jun 2026
- Capital expenditures incurred but not yet paid58 · Dec 2014 to Jun 2026
- Comprehensive income net of tax58 · Dec 2014 to Jun 2026
- Comprehensive income net of tax including portion attributable to noncontrolling interest58 · Dec 2014 to Jun 2026
- Cost of revenue (US GAAP)58 · Dec 2014 to Jun 2026
- Costs and expenses58 · Dec 2014 to Jun 2026
- Deferred income tax expense benefit58 · Dec 2014 to Jun 2026
- Depreciation58 · Dec 2014 to Jun 2026
- Depreciation depletion and amortization58 · Dec 2014 to Jun 2026
- Dividends common stock cash58 · Dec 2014 to Jun 2026
- Income loss from equity method investments58 · Dec 2014 to Jun 2026
- Income taxes paid58 · Dec 2014 to Jun 2026
- Income tax expense benefit58 · Dec 2014 to Jun 2026
- Increase decrease in accounts payable and accrued liabilities58 · Dec 2014 to Jun 2026
- Increase decrease in accounts receivable58 · Dec 2014 to Jun 2026
- Increase decrease in accrued income taxes payable58 · Dec 2014 to Jun 2026
- Increase decrease in other operating capital net58 · Dec 2014 to Jun 2026
- Incremental common shares attributable to share based payment arrangements58 · Dec 2014 to Jun 2026
- Interest income expense net58 · Dec 2014 to Jun 2026
- Minority interest decrease from distributions to noncontrolling interest holders58 · Dec 2014 to Jun 2026
Segment10 concepts · 761 facts · Dec 2014 to Jun 2026
- Percentage of net revenues325 · Dec 2016 to Jun 2026
- Operating income loss174 · Dec 2014 to Jun 2026
- Revenue116 · Dec 2014 to Jun 2026
- Depreciation depletion and amortization66 · Dec 2014 to Jun 2026
- Payments to acquire property plant and equipment27 · Dec 2014 to Dec 2022
- Routine clinical testing services20 · Dec 2021 to Dec 2025
- Segment expenditure addition to long lived assets15 · Dec 2021 to Dec 2025
- Segment reporting other item amount14 · Dec 2022 to Jun 2026
- Percentage of net revenues from Diagnostic Information Services business3 · Dec 2016 to Dec 2018
- Gain loss on sale of business1 · Sep 2015
Guidance9 concepts · 349 facts · Jul 2016 to Jul 2026
- Capital Expenditures Guidance85 · Jul 2016 to Jul 2026
- Revenue Guidance79 · Jul 2016 to Jul 2026
- EPS (Diluted) Guidance75 · Jul 2016 to Jul 2026
- Revenue Growth Guidance64 · Oct 2016 to Jul 2026
- EPS (Diluted) Guidance (Adjusted (non-GAAP))32 · Oct 2016 to Feb 2024
- Revenue Growth Guidance (Comparable)8 · Oct 2016 to Jul 2017
- EPS (Diluted) Guidance (excluding amortization; Adjusted (non-GAAP))2 · Apr 2018
- Operating Margin Guidance2 · Jan 2026
- Revenue Growth Guidance (Adjusted (non-GAAP))2 · Feb 2018
Product3 concepts · 168 facts · Dec 2014 to Dec 2025
- Revenue99 · Dec 2014 to Sep 2022
- Routine clinical testing services65 · Dec 2020 to Dec 2025
- Percentage of net revenues4 · Dec 2022 to Dec 2025
KPI1 concepts · 44 facts · Jun 2016 to Jun 2026
- Average Selling Price per Unit YoY Change44 · Jun 2016 to Jun 2026
Geography1 concepts · 1 facts · Dec 2024
- Canada1 · Dec 2024
Segments
930 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments4 members · 475 facts
- Diagnostic Information Services Business228 · Dec 2014 to Jun 2026
- All Other Segments152 · Dec 2014 to Jun 2026
- Corporate94 · Dec 2014 to Jun 2026
- Clinical Trials1 · Sep 2015
Subsegments6 members · 286 facts
- Healthcare Insurers127 · Dec 2016 to Jun 2026
- Client Payers39 · Dec 2016 to Jun 2026
- DS Businesses39 · Dec 2016 to Jun 2026
- Government Payers39 · Dec 2016 to Jun 2026
- Patients22 · Jun 2019 to Jun 2026
- Patient20 · Dec 2016 to Dec 2025
Product or servicesrt:ProductOrServiceAxis7 members · 148 facts
- Allotherservices28 · Dec 2017 to Dec 2025
- Anatomicpathologytestingservices28 · Dec 2017 to Dec 2025
- Genebasedandesoterictestingservices28 · Dec 2017 to Dec 2025
- Routine Clinical Testing And Other Services28 · Dec 2017 to Dec 2025
- COVID19 Testing Services27 · Dec 2018 to Dec 2025
- DS Revenues5 · Dec 2021 to Dec 2025
- Medicare And Medicaid Programs4 · Dec 2022 to Dec 2025
Product or serviceus-gaap:ProductOrServiceAxis4 members · 20 facts
- Allotherservices5 · Dec 2014 to Dec 2018
- Anatomicpathologytestingservices5 · Dec 2014 to Dec 2018
- Genebasedandesoterictestingservices5 · Dec 2014 to Dec 2018
- Routine Clinical Testing And Other Services5 · Dec 2014 to Dec 2018
Statement geographical1 member · 1 facts
- CA1 · Dec 2024
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary86 claims from 9 reports · Sep 2024 to Jun 2026
- Management discussion (MD&A) commentary70 claims from 4 reports · Sep 2024 to Jun 2026
- Risk-factor changes8 claims from 1 reports · Dec 2025
- Risk factors52 risks from 2 annual reports · 2024 to 2025
Earnings calls
2 calls · Apr 2026 to Jul 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Jul 23, 2026
- FY2026 Q1Apr 21, 2026
Executive media
5 appearancesPodcasts, interviews and conference appearances by the company's executives, with their claims.
- TV interviews4 · May 2020 to Feb 2026
- Other appearances1 · May 2026
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.